Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 362024, 9 pages
http://dx.doi.org/10.1155/2014/362024
Research Article

Effects of Combined Anisodamine and Neostigmine Treatment on the Inflammatory Response and Liver Regeneration of Obstructive Jaundice Rats after Hepatectomy

Department & Institute of Hepatobiliary Surgery, Chinese PLA General Hospital, Chinese PLA Medical College, Beijing 100853, China

Received 9 July 2014; Accepted 11 September 2014; Published 12 November 2014

Academic Editor: Limei Qiu

Copyright © 2014 Chong-Hui Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Suda, M. Ohtsuka, S. Ambiru et al., “Risk factors of liver dysfunction after extended hepatic resection in biliary tract malignancies,” The American Journal of Surgery, vol. 197, no. 6, pp. 752–758, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Nanashima, T. Abo, J. Arai, H. Matsumoto, T. Kudo, and T. Nagayasu, “Functional liver reserve parameters predictive for posthepatectomy complications,” Journal of Surgical Research, vol. 185, no. 1, pp. 127–135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Saito and J. J. Maher, “Bile duct ligation in rats induces biliary expression of cytokine- induced neutrophil chemoattractant,” Gastroenterology, vol. 118, no. 6, pp. 1157–1168, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. J. S. Gujral, A. Farhood, M. L. Bajt, and H. Jaeschke, “Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice,” Hepatology, vol. 38, no. 2, pp. 355–363, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Aller, J. L. Arias, I. Prieto, M. Losada, and J. Arias, “Bile duct ligation: step-by-step to cholangiocyte inflammatory tumorigenesis,” European Journal of Gastroenterology and Hepatology, vol. 22, no. 6, pp. 651–661, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. L. V. Borovikova, S. Ivanova, M. Zhang et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, no. 6785, pp. 458–462, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. W. J. de Jonge and L. Ulloa, “The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation,” British Journal of Pharmacology, vol. 151, no. 7, pp. 915–929, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. B. Marrero, M. Bencherif, P. M. Lippiello, and R. Lucas, “Application of alpha7 nicotinic acetylcholine receptor agonists in inflammatory diseases: an overview,” Pharmaceutical Research, vol. 28, no. 2, pp. 413–416, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Liu, F.-M. Shen, Y.-Y. Le et al., “Antishock effect of anisodamine involves a novel pathway for activating α7 nicotinic acetylcholine receptor,” Critical Care Medicine, vol. 37, no. 2, pp. 634–641, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Hofer, C. Eisenbach, I. K. Lukic et al., “Pharmacologic cholinesterase inhibition improves survival in experimental sepsis,” Critical Care Medicine, vol. 36, no. 2, pp. 404–408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. A. J. Liu, P. Zang, J. M. Guo et al., “Involvement of acetylcholine-α7nAChR in the protective effects of arterial baroreflex against ischemic stroke,” CNS Neuroscience and Therapeutics, vol. 18, no. 11, pp. 918–926, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Sun, G.-F. Zhang, X. Zhang et al., “Combined administration of anisodamine and neostigmine produces anti-shock effects: involvement of α7 nicotinic acetylcholine receptors,” Acta Pharmacologica Sinica, vol. 33, no. 6, pp. 761–766, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J.-X. Zhou, P. Ke, G. Huan, B.-Z. Shao, and C. Liu, “Combined treatment with anisodamine and neostigmine inhibits joint inflammation in collagen-induced arthritis mice,” CNS Neuroscience and Therapeutics, vol. 20, no. 2, pp. 186–187, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. G. M. Higgins and R. M. Anderson, “Experimental pathology of liver resection,” Archives of Pathology, vol. 12, pp. 186–197, 1931. View at Google Scholar
  15. W. de Graaf, M. Heger, O. Spruijt et al., “Quantitative assessment of liver function after ischemia-reperfusion injury and partial hepatectomy in rats,” Journal of Surgical Research, vol. 172, no. 1, pp. 85–94, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Poupko, S. I. Baskin, and E. Moore, “The pharmacological properties of anisodamine,” Journal of Applied Toxicology, vol. 27, no. 2, pp. 116–121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S.-T. Wang and N.-L. Kuo, “Experience in emergency treatment of shock due to infection,” Chinese Medical Journal, vol. 4, no. 6, pp. 497–500, 1978. View at Google Scholar · View at Scopus
  19. X. Rui-Juan, “Studies on microcirculation in Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences,” Microvascular Research, vol. 20, no. 3, pp. 371–373, 1980. View at Publisher · View at Google Scholar · View at Scopus
  20. P. F. Lalor, P. S. Shields, A. J. Grant, and D. H. Adams, “Recruitment of lymphocytes to the human liver,” Immunology and Cell Biology, vol. 80, no. 1, pp. 52–64, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. H. L. van Sweringen, N. Sakai, A. D. Tevar, J. M. Burns, M. J. Edwards, and A. B. Lentsch, “CXC chemokine signaling in the liver: impact on repair and regeneration,” Hepatology, vol. 54, no. 4, pp. 1445–1453, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. T. F. Tracy Jr., P. V. Bailey, M. E. Goerke, C. Sotelo-Avila, and T. R. Weber, “Cholestasis without cirrhosis alters regulatory liver gene expression and inhibits hepatic regeneration,” Surgery, vol. 110, no. 2, pp. 176–183, 1991. View at Google Scholar · View at Scopus
  23. J. M. Dixon, C. P. Armstrong, S. W. Duffy, and G. C. Davies, “Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients,” Gut, vol. 24, no. 9, pp. 845–852, 1983. View at Publisher · View at Google Scholar · View at Scopus
  24. T.-Z. Liu, K.-T. Lee, C.-L. Chern, J.-T. Cheng, A. Stern, and L.-Y. Tsai, “Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor κB,” Annals of Clinical and Laboratory Science, vol. 31, no. 4, pp. 383–390, 2001. View at Google Scholar · View at Scopus
  25. W. Zhou, W. Chao, B. A. Levine, and M. S. Olson, “Role of platelet-activating factor in hepatic responses after bile duct ligation in rats,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 263, no. 5, part 1, pp. G587–G592, 1992. View at Google Scholar · View at Scopus
  26. R. Levy, F. Schlaeffer, A. Keynan, O. Nagauker, A. Yaari, and E. Sikuler, “Increased neutrophil function induced by bile duct ligation in a rat model,” Hepatology, vol. 17, no. 5, pp. 908–914, 1993. View at Publisher · View at Google Scholar · View at Scopus
  27. A. J. Lechner, A. Velasquez, K. R. Knudsen, C. A. Johanns, T. F. Tracy Jr., and G. M. Matuschak, “Cholestatic liver injury increases circulating TNF-α and IL-6 and mortality after Escherichia coli endotoxemia,” The American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 5, pp. 1550–1558, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. L. D. DeLeve, “Liver sinusoidal endothelial cells and liver regeneration,” Journal of Clinical Investigation, vol. 123, no. 5, pp. 1861–1866, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Stehr, F. Ploner, K. Traeger et al., “Plasma disappearance of indocyanine green: a marker for excretory liver function?” Intensive Care Medicine, vol. 31, no. 12, pp. 1719–1722, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Mizuno and S. Isaji, “Indocyanine green (ICG) fluorescence imaging-guided cholangiography for donor hepatectomy in living donor liver transplantation,” The American Journal of Transplantation, vol. 10, no. 12, pp. 2725–2726, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Yoshidome, M. Miyazaki, H. Shimizu et al., “Obstructive jaundice impairs hepatic sinusoidal endothelial cell function and renders liver susceptible to hepatic ischemia/reperfusion,” Journal of Hepatology, vol. 33, no. 1, pp. 59–67, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. S. B. Akinci, N. Ulu, O. Z. Yondem et al., “Effect of neostigmine on organ injury in murine endotoxemia: missing facts about the cholinergic antiinflammatory pathway,” World Journal of Surgery, vol. 29, no. 11, pp. 1483–1489, 2005. View at Publisher · View at Google Scholar · View at Scopus